HALO logo
halo search icon
vTv Therapeutics, Inc. Class A
vTv Therapeutics, Inc. Class A
VTVT · NAS

vTv Therapeutics, Inc. Class A

US$36.60

Price Arrow0.11 (0.301%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Earnings MomentumHALO MomentumHALO Price MomentumHammer BullishHammer Bullish (Realtime)+1
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

vTv Therapeutics, Inc. Class A Overview

VTVT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About VTVT

icon

Telephone

1.336.841.0300

icon

Address

Suite 310, 3980 Premier Drive, High Point, NC 27265

Description

vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and the Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.

VTVT Price Chart

Key Stats

Market Cap

US$143.72M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 14 - 44

Trade Value (12mth)

US$184,187.00

1 week

2.23%

1 month

-5.22%

YTD

-7.85%

1 year

82.54%

All time high

560.00

Key Fundamentals

EPS 3 yr Growth

-68.70%

EBITDA Margin

0.00%

Operating Cashflow

-$25m

Free Cash Flow Return

-64.90%

ROIC

-70.40%

Interest Coverage

NaN

Quick Ratio

13.50

Other Data

Shares Outstanding (Fully Diluted)

15m

HALO Sector

Healthcare

Next Company Report Date

17-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

VTVT Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
14 May 26

VTVT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-9.71-3.2-3.2locklocklock
EPS (Fully Diluted)
$locklocklocklock-9.71-3.2-3.2locklocklock
Growth
%locklocklocklock5.167.1-0.1locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of vTv Therapeutics, Inc. Class A (VTVT:NAS)?
Halo FAQ
The current share price of vTv Therapeutics, Inc. Class A (VTVT:NAS) is USD$36.60.
What is the 52-week high share price for vTv Therapeutics, Inc. Class A (VTVT:NAS)?
Halo FAQ
The 52-week high share price for vTv Therapeutics, Inc. Class A (VTVT:NAS) is USD$44.00.
What is the 52-week low share price for vTv Therapeutics, Inc. Class A (VTVT:NAS)?
Halo FAQ
The 52-week low share price for vTv Therapeutics, Inc. Class A (VTVT:NAS) is USD$14.00.
What is the dividend yield for vTv Therapeutics, Inc. Class A (VTVT:NAS)?
Halo FAQ
vTv Therapeutics, Inc. Class A (VTVT:NAS) does not pay a dividend.
What was vTv Therapeutics, Inc. Class A (VTVT:NAS) last dividend payment?
Halo FAQ
vTv Therapeutics, Inc. Class A (VTVT:NAS) does not pay a dividend.
What is the franking level for vTv Therapeutics, Inc. Class A (VTVT:NAS)?
Halo FAQ
vTv Therapeutics, Inc. Class A (VTVT:NAS) has a franking level of 0.00%.
In which sector is vTv Therapeutics, Inc. Class A (VTVT:NAS) classified?
Halo FAQ
vTv Therapeutics, Inc. Class A (VTVT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.